Sign the Final Beam of the UC Gardner Neuroscience Institute
Weve reached the top! Join us on April 9 to officially commemorate the installation of the last steel beam of the UC Gardner Neuroscience Institute with a beam-signing opportunity for UC Health employees, UC faculty, staff and students.
The 38-foot steel beam will be available on Monday April 9, from 7 a.m. to 7 p.m., at the corner of Bellevue and Piedmont Aves., closest to the Barrett Cancer Center parking lot. Permanent markers will be available at the beam for your signature to become a part of UC Health history.
A final beam signifies the "topping off" for the buildingthat the highest point of steel construction has been reached. Construction began on the four-story patient-centered facility in May 2017. The $60.5 million new home for the institute is expected to be completed in 2019, and will house all outpatient neurologic care, as well as and patient education activities and improved access to advanced clinical trials.
University of Cincinnati Gardner Neuroscience Institute building rendering
Construction site of 223 Piedmont Ave., new facility for the UC Gardner Neuroscience Institute
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.